Abstract:Liver tissues were obtained from 20 liver cancer patients from Thailand, an area where the incidence of this tumour is high and where exposure to aflatoxin occurs. The expression of hepatic cytochrome P450s (P450) and glutathione S-transferase (GST) was examined and this expression was compared to the in vitro metabolism of aflatoxin B1 (AFB1). There was a > 10-fold inter-individual variation in expression of the various P450s including CYP3A4 (57-fold), CYP2B6 (56-fold) and CYP2A6 (120-fold). Microsomal metabolism of AFB1 to AFB1 8,9-epoxide (as measured by AFB1 tris-diol formation) and aflatoxin Q1 (AFQ1), the major metabolite produced, was significantly correlated with CYP3A3/4 expression (P < 0.001) and, to a lesser extent, with CYP2B6 expression (P < 0.01). There was a significantly reduced expression of major P450 proteins in microsomes from liver tumours compared to microsomes from the paired normal liver when analysed by Western immunoblot analysis. The production of AFQ1 and AFB1 tris-diol was almost uniformly reduced in tumours, but interestingly, the production of AFP1 was significantly increased. The immunoreactive expression of the major human classes of cytosolic GSTs (alpha, mu and pi) was also analyzed in normal and tumorous liver tissue. The expression of GSTA (alpha) and GSTM (mu) class proteins was markedly decreased and GSTP (pi) increased in the majority of tumour cytosols compared to normal liver. The cytosolic GST activity (1-chloro-2,4-dinitrobenzene conjugation) was significantly lower in liver tumours compared to normal liver (193 +/- 149 versus 875 +/- 299 nmol/min/mg, P < 0.0001), as was glutathione peroxidase (GPx) activity (cumene hydroperoxide) (26 +/- 23 versus 70 +/- 26 nmol/min/mg respectively, P < 0.005). Ten out of 14 individuals (71%) were homozygous null when genotyped for GSTM1. There was no detectable conjugation of AFB1 8,9-epoxide to glutathione by cytosol either from tumorous or normal liver. Thus, capacity of human cytosols to conjugate reactive AFB1 metabolites to GSH resembled AFB1-sensitive species such as rat, trout and duck rather than resistant species such as mouse and hamster. These data indicate a strong capacity of multiple forms of human hepatic P450s to metabolize AFB1 to both the reactive intermediate AFB1 8,9-epoxide and the detoxification product AFQ1. These results suggest that in view of the lack of significant GST-mediated protection against AFB1 in human liver, variations in expression of hepatic P450, due either to genetic polymorphisms or to modulation by environmental factors, may be important determinants in the risk of liver cancer development in AFB1-exposed populations.

Metabolism of chlorambucil by rat liver microsomal glutathione S-transferase.

Relationship between activation of microsomal glutathione S-transferase and metabolism behavior of chlorambucil.

Metabolism of melphalan by rat liver microsomal glutathione S-transferase.

Activation of rat liver microsomal glutathione S-transferase by chlorambucil and cyclophosphamide in vitro

[Augmentation of Rat Liver Microsome Glutathione S-transferase Preparation]

Mechanism of activation of mouse liver microsomal glutathion S-transferase enhanced by paracetamol treatment in vivo

Modeling the metabolic competency of glutathione S-transferases using genetically modified cell lines

Reduced levels of drug-induced DNA cross-linking in nitrogen mustard-resistant Chinese hamster ovary cells expressing elevated glutathione S-transferase activity.

Specificity of Murine Glutathione S-Transferase Isozymes in the Glutathione Conjugation of (-)-anti- and (+)-Syn-stereoisomers of Benzo[G]Chrysene 11,12-Diol 13,14-Epoxide

Dual Approach: Micellar Delivery of Chlorambucil Prodrug with Concurrent Glutathione Depletion and GST Inhibition for Enhanced Anticancer Activity

Differential Catalytic Efficiency of Allelic Variants of Human GlutathioneS-Transferase Pi in Catalyzing the Glutathione Conjugation of Thiotepa,

CYP3A4-Mediated Metabolic Activation and Cytotoxicity of Chlortoluron

In vitro metabolism of aflatoxin B1 by normal and tumorous liver tissue from Thailand

Mechanism of Differential Catalytic Efficiency of Two Polymorphic Forms of Human GlutathioneS-Transferase P1-1 in the Glutathione Conjugation of Carcinogenic Diol Epoxide of Chrysene

Differential Enantioselectivity of Murine Glutathione S-transferase Isoenzymes in the Glutathione Conjugation of Trans-3,4-dihydroxy-1, 2-Oxy-1,2,3,4-tetrahydrobenzo[c]phenanthrene Stereoisomers.

Characterization of primary glutathione conjugates with acrylamide and glycidamide: Toxicokinetic studies in Sprague Dawley rats treated with acrylamide

The effect of transcatheter arterial chemoembolization on phase II drug metabolism enzymes in patients with hepatocellular carcinoma

Bioactivation of 1-Chloro-2-hydroxy-3-butene, an in Vitro Metabolite of 1,3-Butadiene, by Rat Liver Microsomes

Chloride and Other Anions Inhibit Dichloroacetate-Induced Inactivation of Human Liver GSTZ1 in a Haplotype-Dependent Manner.

Methoxylated Modification of Glutathione-Mediated Metabolism of Halobenzoquinones In Vivo and In Vitro

Characterization of metabolic activity, isozyme contribution and species differences of bavachin, and identification of efflux transporters for bavachin-<i>O</i>-glucuronide in HeLa1A1 cells